We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
+14.3%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$697M
AUM Growth
+$86.6M
Cap. Flow
+$8.37M
Cap. Flow %
1.2%
Top 10 Hldgs %
31.77%
Holding
194
New
19
Increased
51
Reduced
73
Closed
4

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$4.1M
2
MRVL icon
Marvell Technology
MRVL
+$3.89M
3
AMGN icon
Amgen
AMGN
+$3.51M
4
ABBV icon
AbbVie
ABBV
+$2.14M
5
UNP icon
Union Pacific
UNP
+$2.1M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.09M
2
MTCH icon
Match Group
MTCH
+$2.43M
3
LHX icon
L3Harris
LHX
+$2.25M
4
INTC icon
Intel
INTC
+$2.05M
5
PPLI
People Inc
PPLI
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 27.19%
2 Healthcare 19%
3 Financials 10.25%
4 Industrials 9.74%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BL icon
151
BlackLine
BL
$1.7B
$297K 0.04%
+2,225
New +$248K
SPSC icon
152
SPS Commerce
SPSC
$2.69B
$288K 0.04%
2,650
SLB icon
153
SLB Ltd
SLB
$78.9B
$284K 0.04%
13,010
-375
-3% -$7.08K
EA
154
DELISTED
Electronic Arts
EA
$283K 0.04%
1,970
+380
+24% +$49K
VB icon
155
Vanguard Morningstar Small-Cap ETF
VB
$82.5B
$282K 0.04%
+1,448
New +$255K
VTRS icon
156
Viatris
VTRS
$18.7B
$281K 0.04%
+15,014
New +$245K
FOXF icon
157
Fox Factory Holding Corp
FOXF
$882M
$280K 0.04%
+2,650
New +$241K
RGEN icon
158
Repligen
RGEN
$9.21B
$280K 0.04%
1,460
-240
-14% -$43.7K
BR icon
159
Broadridge
BR
$19.8B
$276K 0.04%
1,800
VO icon
160
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$273K 0.04%
5,280
DVY icon
161
iShares Select Dividend ETF
DVY
$23.6B
$272K 0.04%
2,832
TRV icon
162
Travelers Companies
TRV
$78.3B
$272K 0.04%
1,935
-67
-3% -$8.6K
RDS.A
163
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$272K 0.04%
7,730
-3,327
-30% -$104K
OMCL icon
164
Omnicell
OMCL
$1.7B
$270K 0.04%
+2,250
New +$221K
NVO
165
Novo Nordisk
NVO
$211B
$267K 0.04%
7,650
RF icon
166
Regions Financial
RF
$26.8B
$262K 0.04%
16,272
+4,382
+37% +$63.4K
VHT icon
167
Vanguard Health Care ETF
VHT
$19B
$259K 0.04%
+1,156
New +$247K
EXPD icon
168
Expeditors International
EXPD
$23.3B
$257K 0.04%
2,700
+200
+8% +$18.2K
SITE icon
169
SiteOne Landscape Supply
SITE
$4.34B
$254K 0.04%
+1,600
New +$219K
DSGX icon
170
Descartes Systems
DSGX
$6.86B
$250K 0.04%
4,280
YUM icon
171
Yum! Brands
YUM
$39.7B
$250K 0.04%
2,302
MRCY icon
172
Mercury Systems
MRCY
$6.52B
$247K 0.04%
2,800
RVTY icon
173
Revvity
RVTY
$12.9B
$244K 0.04%
1,700
EXPO icon
174
Exponent
EXPO
$3.28B
$243K 0.03%
+2,700
New +$215K
FSV icon
175
FirstService
FSV
$6.27B
$243K 0.03%
1,780

Similar funds

Marco Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Marco Investment Management held 194 positions worth $697M, up 14% from $610M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Marco Investment Management's Q4 2020 filing shows 19 new, 51 increased, 73 reduced and 4 closed positions. Its largest new stake was Illumina: 12,850 shares worth $4.63M. The largest sale was CVS Health, an estimated $3.09M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Marco Investment Management's largest Q4 2020 buy was Illumina: 12,850 shares worth $4.63M.
  • Marco Investment Management added most to Amgen in Q4 2020, an estimated $3.51M increase.
  • Marco Investment Management's biggest Q4 2020 reduction was CVS Health, cutting an estimated $3.09M.
  • Marco Investment Management fully exited Match Group in Q4 2020, selling an estimated $2.43M.
  • Marco Investment Management's ten largest holdings make up 32% of its $697M portfolio in Q4 2020.
  • Marco Investment Management opened 19 new positions and closed 4 in Q4 2020.
  • Marco Investment Management's portfolio value rose 14% quarter-over-quarter to $697M.

Based on Marco Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.